According to the new market research report “Dental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital)- Global Forecast to 2025“, published by MarketsandMarkets™, the global Dental Bone Graft Substitute Market size is estimated to be USD 450 million in 2020 and projected to reach USD 659 million by 2025, at a CAGR of 7.9%.
Download PDF Brochure:
The Increasing prevalence of orthopedic diseases & disorders, continuous product commercialization, greater product affordability & market availability, rising number of sports and accident-related injuries, and growing public awareness related to preventive care are the key factors driving the growth of the orthopedic braces and supports industry.
The dental bone graft substitute market includes major Tier I and II suppliers like Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for dental bone graft substitutes from key end-users has significantly declined amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term negative growth for the market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.
Browse in-depth TOC on “Dental Bone Graft Substitute Market”
91 – Tables
34 – Figures
147 – Pages
Demand for synthetic bone graft result in the segment occupying the high share of the market
Synthetic bone graft segment owes a good market share in Dental bone graft substitute market. Synthetic bones are derived from genetically unrelated members of the same species, like cadaver bone. Using patient’s own bone has traditionally been the most preferred method bone grafting, however the increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease to get transferred. Because of these benefits synthetic bone graft is the fastest growing type in the dental bone graft substitutes market.
Xenograft estimated to be the largest growing market
Xenograft are estimated to be the largest growing segment in the dental bone graft substitue market. The growth of this segment can be attributed to source for allograft materials are highly scarce and technological advances of xenograft materials are more recent for the dental application.
Europe is the region of origin of implant dentistry; therefore, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the European dental market are the increase in aging population, governmental expenditure on oral healthcare across Europe, and the high reimbursement rate—although limited to Germany, Sweden, and the Netherlands.
Request Sample Report:
Asia Pacific likely to emerge as the fastest growing dental bone graft substitute market, globally
Asia Pacific is estimated to be the fastest-growing market for dental bone graft substitute during the forecast period. The Asia Pacific market is driven principally by the rising geriatric and obese population (coupled with the significant prevalence of orthopedic & diabetes-related diseases in this population segment), increasing GDP and healthcare expenditure in APAC countries, and growing public awareness. Furthermore, increasingly localized product manufacturing, favorable government regulations, and the focus of global product manufacturers on expanding their presence in APAC countries are aiding the market growth.
Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland) are the key players in the global dental bone graft substitute global dental bone graft substitute market.